These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 25420630)
1. Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo. Pan Y; Zhang L; Zhang X; Liu R Oncol Rep; 2015 Feb; 33(2):774-82. PubMed ID: 25420630 [TBL] [Abstract][Full Text] [Related]
2. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth. Zhang L; Gao L; Li Y; Lin G; Shao Y; Ji K; Yu H; Hu J; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ Clin Cancer Res; 2008 Jan; 14(2):559-68. PubMed ID: 18223232 [TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of eukaryotic coexpression plasmid carrying LKB1 and FUS1 genes on lung cancer in vitro and in vivo. Li L; Yu C; Ren J; Ye S; Ou W; Wang Y; Yang W; Zhong G; Chen X; Shi H; Su X; Chen L; Zhu W J Cancer Res Clin Oncol; 2014 Jun; 140(6):895-907. PubMed ID: 24659339 [TBL] [Abstract][Full Text] [Related]
4. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo. Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell line in vitro and in vivo. Huang F; Tong X; Fu L; Zhang R Acta Biochim Biophys Sin (Shanghai); 2008 Jun; 40(6):519-25. PubMed ID: 18535750 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway. Liu T; Qin W; Hou L; Huang Y Tumour Biol; 2015 Mar; 36(3):1881-93. PubMed ID: 25510663 [TBL] [Abstract][Full Text] [Related]
7. Efficient inhibition of intraperitoneal ovarian cancer growth in nude mice by liposomal delivery of short hairpin RNA against STAT3. Jiang Q; Dai L; Cheng L; Chen X; Li Y; Zhang S; Su X; Zhao X; Wei Y; Deng H J Obstet Gynaecol Res; 2013 Mar; 39(3):701-9. PubMed ID: 23003327 [TBL] [Abstract][Full Text] [Related]
8. Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth. Liu YB; Zhang L; Guo YX; Gao LF; Liu XC; Zhao LJ; Guo BF; Zhao LJ; Zhao XJ; Xu DQ Asian J Androl; 2012 Jul; 14(4):536-45. PubMed ID: 22580637 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice. Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845 [TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC). Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947 [TBL] [Abstract][Full Text] [Related]
11. Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3. Sengupta S; Nagalingam A; Muniraj N; Bonner MY; Mistriotis P; Afthinos A; Kuppusamy P; Lanoue D; Cho S; Korangath P; Shriver M; Begum A; Merino VF; Huang CY; Arbiser JL; Matsui W; Győrffy B; Konstantopoulos K; Sukumar S; Marignani PA; Saxena NK; Sharma D Oncogene; 2017 Oct; 36(41):5709-5721. PubMed ID: 28581518 [TBL] [Abstract][Full Text] [Related]
12. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells. Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233 [TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer]. Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of LKB1 suppresses Stat3 activity to promote the proliferation of esophageal carcinoma cells. Wang YQ; Dai WM; Chu XY; Yang B; Zhao M; Sun Y Mol Med Rep; 2014 Jun; 9(6):2400-4. PubMed ID: 24676538 [TBL] [Abstract][Full Text] [Related]
15. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC. Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938 [TBL] [Abstract][Full Text] [Related]
17. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells]. Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458 [TBL] [Abstract][Full Text] [Related]
18. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220 [TBL] [Abstract][Full Text] [Related]
19. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917 [TBL] [Abstract][Full Text] [Related]
20. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer. Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]